TLP
Tri Locum Partners Portfolio holdings
AUM
$330M
This Quarter Return
-2.32%
1 Year Return
+35.44%
3 Year Return
+388.28%
5 Year Return
–
10 Year Return
–
AUM
$243M
AUM Growth
+$243M
(-5.1%)
Cap. Flow
+$6.2M
Cap. Flow
% of AUM
2.55%
Top 10 Holdings %
Top 10 Hldgs %
62.43%
Holding
66
New
29
Increased
14
Reduced
7
Closed
16
Top Buys
| 1 |
argenx
ARGX
|
$17.8M |
| 2 |
CTLT
CATALENT, INC.
CTLT
|
$11.6M |
| 3 |
Eli Lilly
LLY
|
$9.1M |
| 4 |
Guardant Health
GH
|
$7.76M |
| 5 |
Stevanato
STVN
|
$7.47M |
Top Sells
| 1 |
Protagonist Therapeutics
PTGX
|
$18.2M |
| 2 |
Regeneron Pharmaceuticals
REGN
|
$15M |
| 3 |
Jazz Pharmaceuticals
JAZZ
|
$11.4M |
| 4 |
INBX
Inhibrx, Inc. Common Stock
INBX
|
$9.06M |
| 5 |
Bristol-Myers Squibb
BMY
|
$8.97M |
Sector Composition
| 1 | Healthcare | 89.29% |
| 2 | Consumer Staples | 4.85% |
| 3 | Industrials | 0.1% |
| 4 | Real Estate | 0.04% |
| 5 | Materials | 0.04% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
Adicet Bio
ACET
$60.8M
| $2.68M | 1.1% |
183,857
-339,399
| -65% | -$4.95M |
|
27
Evolus
EOLS
$477M
| $2.53M | 1.03% |
+217,767
| New | +$2.53M |
|
|
SNCE
28
DELISTED
Science 37 Holdings, Inc. Common Stock
SNCE
| $2.08M | 0.85% |
+1,036,194
| New | +$2.08M |
|
29
X4 Pharmaceuticals
XFOR
$70M
| $1.68M | 0.69% |
1,738,300
+20,711
| +1% | +$20K |
|
30
Amylyx Pharmaceuticals
AMLX
$877M
| $1.55M | 0.63% |
+80,459
| New | +$1.55M |
|
31
3M
MMM
$81B
| $210K | 0.09% |
+1,619
| New | +$210K |
|
32
Femasys
FEMY
$12M
| $202K | 0.08% |
83,831
-4,121
| -5% | -$9.93K |
|
33
Annaly Capital Management
NLY
$13.8B
| $104K | 0.04% |
17,666
+1,607
| +10% | +$9.47K |
|
34
Transocean
RIG
$2.82B
| $66K | 0.03% |
+19,683
| New | +$66K |
|
|
ALLK
35
DELISTED
Allakos
ALLK
| $63K | 0.03% |
+20,029
| New | +$63K |
|
36
NovaGold Resources
NG
$2.73B
| $55K | 0.02% |
+11,433
| New | +$55K |
|
37
Shattuck Labs
STTK
$61.3M
| $54K | 0.02% |
+13,230
| New | +$54K |
|
38
AvePoint
AVPT
$3.41B
| $53K | 0.02% |
+12,140
| New | +$53K |
|
39
Nektar Therapeutics
NKTR
$543M
| $51K | 0.02% |
+13,402
| New | +$51K |
|
40
CEL-SCI Corp
CVM
$81.4M
| $50K | 0.02% |
+11,206
| New | +$50K |
|
41
Advantage Solutions
ADV
$551M
| $46K | 0.02% |
+12,156
| New | +$46K |
|
|
LEV
42
DELISTED
The Lion Electric Company
LEV
| $44K | 0.02% |
+10,466
| New | +$44K |
|
43
Wheels Up
UP
$1.63B
| $39K | 0.02% |
+19,892
| New | +$39K |
|
44
Skillsoft
SKIL
$133M
| $38K | 0.02% |
+10,891
| New | +$38K |
|
|
ME
45
DELISTED
23andMe Holding Co. Class A Common Stock
ME
| $36K | 0.01% |
+14,367
| New | +$36K |
|
|
GATO
46
DELISTED
Gatos Silver, Inc.
GATO
| $35K | 0.01% |
+12,062
| New | +$35K |
|
47
Aligos Therapeutics
ALGS
$75.1M
| $35K | 0.01% |
+29,302
| New | +$35K |
|
48
Aveanna Healthcare
AVAH
$1.74B
| $34K | 0.01% |
15,151
+4,303
| +40% | +$9.66K |
|
|
MKFG
49
DELISTED
Markforged Holding Corporation
MKFG
| $33K | 0.01% |
+17,585
| New | +$33K |
|
|
DOMA
50
DELISTED
Doma Holdings, Inc.
DOMA
| $23K | 0.01% |
+21,974
| New | +$23K |
|